Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sets New 52-Week High – What’s Next?

Posted by Renee Jackson on Feb 22nd, 2025

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) hit a new 52-week high during mid-day trading on Saturday . The stock traded as high as $20.00 and last traded at $19.50, with a volume of 39684 shares changing hands. The stock had previously closed at $17.41.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group raised their price objective on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th.

Get Our Latest Report on Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

The stock’s 50-day simple moving average is $16.67.

About Telix Pharmaceuticals Limited American Depositary Shares

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.